Cargando…

The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy

Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Ariel C., Kanwal, Fasiha, Asrani, Sumeet K., Thrift, Aaron P., Amos, Chris I., Jibaja-Weiss, Maria L., Montealegre, Jane R., Hwang, Jessica P., Singal, Amit G., El-Serag, Hashem B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437299/
https://www.ncbi.nlm.nih.gov/pubmed/36059708
http://dx.doi.org/10.3389/fonc.2022.953933
_version_ 1784781571902930944
author Harrison, Ariel C.
Kanwal, Fasiha
Asrani, Sumeet K.
Thrift, Aaron P.
Amos, Chris I.
Jibaja-Weiss, Maria L.
Montealegre, Jane R.
Hwang, Jessica P.
Singal, Amit G.
El-Serag, Hashem B.
author_facet Harrison, Ariel C.
Kanwal, Fasiha
Asrani, Sumeet K.
Thrift, Aaron P.
Amos, Chris I.
Jibaja-Weiss, Maria L.
Montealegre, Jane R.
Hwang, Jessica P.
Singal, Amit G.
El-Serag, Hashem B.
author_sort Harrison, Ariel C.
collection PubMed
description Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030.
format Online
Article
Text
id pubmed-9437299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94372992022-09-03 The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy Harrison, Ariel C. Kanwal, Fasiha Asrani, Sumeet K. Thrift, Aaron P. Amos, Chris I. Jibaja-Weiss, Maria L. Montealegre, Jane R. Hwang, Jessica P. Singal, Amit G. El-Serag, Hashem B. Front Oncol Oncology Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030. Frontiers Media S.A. 2022-08-19 /pmc/articles/PMC9437299/ /pubmed/36059708 http://dx.doi.org/10.3389/fonc.2022.953933 Text en Copyright © 2022 Harrison, Kanwal, Asrani, Thrift, Amos, Jibaja-Weiss, Montealegre, Hwang, Singal and El-Serag https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Harrison, Ariel C.
Kanwal, Fasiha
Asrani, Sumeet K.
Thrift, Aaron P.
Amos, Chris I.
Jibaja-Weiss, Maria L.
Montealegre, Jane R.
Hwang, Jessica P.
Singal, Amit G.
El-Serag, Hashem B.
The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title_full The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title_fullStr The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title_full_unstemmed The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title_short The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
title_sort texas collaborative center for hepatocellular cancer: reducing liver cancer mortality in texas through coordination, collaboration and advocacy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437299/
https://www.ncbi.nlm.nih.gov/pubmed/36059708
http://dx.doi.org/10.3389/fonc.2022.953933
work_keys_str_mv AT harrisonarielc thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT kanwalfasiha thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT asranisumeetk thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT thriftaaronp thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT amoschrisi thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT jibajaweissmarial thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT montealegrejaner thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT hwangjessicap thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT singalamitg thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT elseraghashemb thetexascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT harrisonarielc texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT kanwalfasiha texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT asranisumeetk texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT thriftaaronp texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT amoschrisi texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT jibajaweissmarial texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT montealegrejaner texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT hwangjessicap texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT singalamitg texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy
AT elseraghashemb texascollaborativecenterforhepatocellularcancerreducinglivercancermortalityintexasthroughcoordinationcollaborationandadvocacy